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Abstract
H5N6 highly pathogenic avian influenza virus (HPAIV) clade 2.3.4.4 not only exhibits
unprecedented intercontinental spread in poultry, but can also cause serious infection in
humans, posing a public health threat. Phylogenetic analyses show that 40% (8/20) of
H5N6 viruses that infected humans carried H9N2 virus-derived internal genes. However,
the precise contribution of H9N2 virus-derived internal genes to H5N6 virus infection in
humans is unclear. Here, we report on the functional contribution of the H9N2 virus-derived
matrix protein 1 (M1) to enhanced H5N6 virus replication capacity in mammalian cells.
Unlike H5N1 virus-derived M1 protein, H9N2 virus-derived M1 protein showed high binding
affinity for H5N6 hemagglutinin (HA) protein and increased viral progeny particle release in
different mammalian cell lines. Human host factor, G protein subunit beta 1 (GNB1), exhib-
ited strong binding to H9N2 virus-derived M1 protein to facilitate M1 transport to budding
sites at the cell membrane. GNB1 knockdown inhibited the interaction between H9N2 virus-
derived M1 and HA protein, and reduced influenza virus-like particles (VLPs) release. Our
findings indicate that H9N2 virus-derived M1 protein promotes avian H5N6 influenza virus
release from mammalian, in particular human cells, which could be a major viral factor for
H5N6 virus cross-species infection.
Author summary
H9N2 avian influenza viruses (AIVs), through reassortment of their internal genes with
other circulating AIVs subtypes (H5N6, H7N9, H10N8 and H10N3 viruses), are known to
enable the resulting novel reassortants to infect humans. However, the precise roles of
H9N2 virus-derived internal genes in human infection remain unknown. Here, we found
that H9N2 virus-derived (but not H5N1 virus-derived) M1 protein showed strong inter-
action with host GNB1 protein to enhance M1 protein transport to budding sites at the
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cell membrane to promote progeny virus release, hence facilitating H5N6 reassortants to
infect human cells.
Introduction
AIVs pose a constant threat to public health by regularly crossing host-species barriers to infect
humans. H5N1 HPAIV has caused at least 863 reported human cases at around 53% mortality
[1]. Since the first H5N6 virus infection in humans in China in 2014, there are to date 47
reported infections and 24 deaths[2]. H7N9 AIVs emerged in China in 2013 and subsequently
caused five influenza epidemics[3]. Avian H9N2 viruses circulate globally through wild birds
and are endemic in domestic poultry in China and elsewhere. Recent studies indicate that
H9N2 viruses are capable of binding to the human-type sialic acid (SA) receptor and are trans-
missible among ferrets via respiratory droplets[4]. As of December 2020, at least 66 global
cases of H9N2 infections in humans have been reported[5].
Genetic drift and genetic reassortment are two types of evolutionary changes that occur in
influenza viruses[6]. The G57 genotype of H9N2 AIVs is regarded as a principal donor of viral
genes through reassortment with co-circulating influenza viruses and resulted in zoonotic
reassortants (H5N6, H7N9, H10N8 and H10N3 viruses)[7–12], indicating that the H9N2
virus-derived internal genes are crucial in the cross-species transmission of AIVs to humans.
Among such reassortants, H7N9, H10N8 and H10N3 viruses are endemic in China; while
H5N6 viruses have been reported in several countries carried by migratory birds[13–15].
Globally, from 2015 to 2021, there were only 7 reported cases of human infection with avian
influenza A (H5N1) virus, while 45 new human cases of avian influenza A (H5N6) virus infec-
tion were reported to the World Health Organization (WHO), suggesting that the H5N6 virus
poses a bigger threat to public health[2]. In addition, H5N6 viruses have also been isolated
from other mammals, including cats and pigs[16,17]. Furthermore, clade 2.3.4.4 H5N6 viruses
can bind both avian- and human-like SA receptors and have higher transmissibility than
H5N1 viruses in experimental ferrets[18–21]. All these findings indicate that H5N6 viruses
pose a serious threat to public health. Therefore, whether the H9N2 virus-derived internal
genes confer a replication advantage to H5N6 viruses in mammalian hosts needs to be
determined.
A key feature of the G57 H9N2 virus is the replacement of the earlier A/chicken/Beijing/1/
1994 (BJ/94)-like M gene with the A/quail/Hong Kong/G1/1997 (G1)-like M gene of quail ori-
gin[22]. The M gene regulates multiple processes during influenza A virus replication through
the M1 protein and the proton channel protein (M2)[23,24]. The M1 protein is the most abun-
dant viral protein responsible for the structural shell of the virus linking the viral envelope
with the nucleocapsid[23]; it is involved in the shuttling of the viral ribonucleoprotein (vRNP)
complex between the nucleus and cytoplasm during viral replication[25–27]. When bound to
HA and neuraminidase (NA), M1 protein serves as a docking site for vRNP and M2 recruit-
ment to virus budding sites, which polymerize and form the emerging virion. Hence, M1 pro-
tein provides structure to the virion and bridges interactions between the viral lipid membrane
and the vRNP core for virus assembly and budding[28,29]. The M2 protein is an integral
membrane protein in the viral envelope with proton channel activity[24]. M1 and M2 proteins
are thus essential in influenza virus assembly and budding, and determine virus morphology
[23]. Mutations in M gene have been found to be critical in affecting viral replication, pathoge-
nicity and cross-species infection[30–32].
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Here, we report on cross-species transmission role of the H9N2 virus-derived M1 protein
in conferring H5N6 viruses with higher replication efficiency in mammalian cells. Human
host factor, GNB1, showed enhanced binding to H9N2 virus-derived M1 protein to promote
M1 transport to the cell membrane which, in turn, facilitated the interaction between M1 and
HA proteins, ultimately improving viral assembly and release.
Results
Reassortment of H9N2 virus-derived M gene enhanced H5N6 virus
replication in mammalian cells
Presently, the number of reported human cases of H5N6 virus infection is 47, and the genome
sequences of 20 cases have been ascertained. Phylogenetic analysis of H5N6 viruses, using
RAxML[33], found that the internal genes could be grouped into multiple genotypes based on
the genetic reassortment with H5N1 virus, H9N2 virus, or waterfowl-origin low pathogenic
avian influenza virus (LPAIV) (Figs 1A and S1 and S1 Table). Further analysis showed that
11.7% (82/703) of H5N6 viruses circulating in poultry carried reassorted H9N2 virus-derived
internal genes, while H5N6 viruses that infected humans carried reassorted H9N2 virus-
derived internal genes at 40.0% (8/20) (Fig 1B).
To investigate the contribution of the H9N2 virus-derived M gene to H5N6 virus replica-
tion in mammalian cells, a reverse genetics-derived H5N6 virus (rM14:M-H9N2), from a
wild-type H5N6 isolate (A/goose/Northern China/M14/2016) containing H9N2 virus-derived
internal genes, was generated. Eight genes of the M14 virus shared high nucleotide identity
with human-isolated H5N6 viruses possessing H9N2-derived internal genes, with identities
Fig 1. Phylogenetic analysis of H5N6 viruses. (A) Phylogenetic analysis of H5N6 viruses in China. The clade origins
of each internal gene are indicated by different colored bars. Detailed phylogenetic trees are available as S1 Fig and S1
Table. H5N6 human strains are marked as red circles, virus labeled with a red asterisk was used in the present research.
(B) Frequencies of H5N6 viruses carrying H9N2 virus-derived internal genes of human and avian origin.
https://doi.org/10.1371/journal.ppat.1010098.g001
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ranging from 96.3 ± 2.2% (for the PB2 gene) to 98.6 ± 0.6% (for the M gene), indicating a con-
sistent genotype (S2 Table). Another virus reassortant with H5N1-derived M gene (rM14:
M-H5N1) in the rM14 virus background was also generated (Fig 2A). Multistep replication
kinetics assays of rM14:M-H9N2 and rM14:M-H5N1 were performed with a multiplicity of
infection (MOI) of 0.01 in embryonic chicken fibroblast cells (DF-1), Madin-Darby canine
kidney cells (MDCK), human airway epithelial cells (Calu-3), and human alveolar basal epithe-
lial cells (A549) over 72 h. There was no difference in virus titers between the two viruses in
DF-1 cells (Fig 2B). However, MDCK and A549 cells infected with rM14:M-H9N2 virus pro-
duced more infectious virus than those infected with rM14:M-H5N1 virus from 12 h post-
infection (hpi) (P< 0.05). At their peak, the mean output of rM14:M-H9N2 virus were up to
10-fold higher than that of rM14:M-H5N1 virus (Fig 2C and 2D). In Calu-3 cells, at 36 to 48
hpi, rM14:M-H9N2 virus produced more viable progeny viruses (P< 0.05) than those of
Fig 2. Reassortment of the H9N2 virus-derived M gene enhanced H5N6 virus replication in mammalian cells. (A)
Gene origins of rM14:M-H9N2 and rM14:M-H5N1 viruses. (B-E) Multistep growth curves of rM14:M-H9N2 and
rM14:M-H5N1 viruses in DF-1, MDCK, A549 and Calu-3 cells, respectively (MOI of 0.01). Virus titers were
determined from the supernatants collected at the indicated time points. Statistical significance was based on one-way
ANOVA (�, P< 0.05; ��, P< 0.01).
https://doi.org/10.1371/journal.ppat.1010098.g002
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rM14:M-H5N1 virus (Fig 2E). Together, these results suggest that the H9N2 virus-derived M
gene improves the ability of H5N6 virus to replicate in mammalian cells.
Enhanced binding interaction between H9N2 virus-derived M1 and H5N6
HA proteins in mammalian cells
M1 and HA proteins promote the budding of progeny influenza viruses[34,35]. To investigate
whether H5N6 HA showed differences in co-localization with H9N2-derived and H5N1-der-
ived M1, confocal microscopy was performed on DF-1 and A549 cells separately infected with
the two recombinant H5N6 viruses (rM14:M-H5N1 and rM14:M-H9N2, MOI = 1). In DF-1
cells, there was no difference in the co-localization of HA and M1 proteins in cells infected
with each virus (Fig 3A). However, in A549 cells, rM14:M-H9N2 virus infection exhibited visi-
bly stronger co-localization of HA and M1 proteins than that of rM14:M-H5N1 virus infection
(Fig 3B).
To examine the co-localization dynamics between the viral M1 and HA proteins at the plasma
membrane of A549 cells, we performed live imaging at different time points over 24 h post-trans-
fection. Plasma membrane was labeled with CellMask Plasma Membrane 647. Pearson’s coeffi-
cient of co-localized volume between H9N2 virus-derived eGFP-M1 and BFP-HA at the plasma
membrane ranged from 0.72 to 0.88 in 36-time frames, while that between H5N1-derived
eGFP-M1 and BFP-HA ranged from 0.55 to 0.44 (Fig 3C). These results indicate that H9N2
virus-derived M1 shows greater co-localization with H5N6 HA at the plasma membrane.
Next, we determined the specific interaction between M1 and HA proteins using co-immu-
noprecipitation (Co-IP) assay. In DF-1 cells, the binding between H9N2-derived M1 and HA
proteins was similar to that of H5N1-derived M1 and HA proteins (Fig 3D). In mammalian
cells, greater binding was observed between H9N2-derived M1 and HA proteins than that
between H5N1-derived M1 and HA proteins (Figs 3E and S2).
To confirm the physical interaction between M1 and HA proteins in mammalian cells,
H5N6 HA gene expression plasmids were co-transfected with M1 gene expression plasmids of
different origins (H9N2- or H5N1-derived M1) in the human embryonic kidney cell line
(293T). Protein interaction was determined by proximity ligation assay (PLA), in which protein
interactions were localized using antibodies specific for viral proteins HA and M1. The human
seasonal virus A/Kansas/14/2017 (H3N2) was used as control. As shown in the Fig 3F–3J, only
faint PLA signals were observed in cells co-transfected with H5N6 HA and H5N1-derived M1
encoding plasmids at 24 h post-transfection (Fig 3F). However, the fluorescence intensity of the
PLA signal was significantly higher in the cells co-transfected with H3N2-derived M1 and
H3N2-derived HA carrying plasmids (P< 0.05) (Fig 3H). In turn, the fluorescence intensity of
the PLA signal in the cells co-transfected with HA and H9N2-derived M1 carrying plasmids
was the highest compared with the other two viruses (P< 0.01) (Fig 3G and 3J).
To identify the key regions where the M1 protein interacts with the HA protein, we trun-
cated the M1 protein to detect interaction of truncated versions with the HA. Results show
that the M1 C-terminal domain is a key region for interaction with HA (S3 Fig). Collectively,
H9N2 virus-derived M1 shows higher binding affinity than H5N1-derived M1 for H5N6 HA
protein in mammalian cells.
H9N2 virus-derived M1 protein increased viral progeny particle release in
mammalian cells
To assess the effect of interaction between H5 HA and M1 proteins on virus budding and
assembly, 293T cells were co-transfected with H5 HA gene expression and H9N2-, or
H5N1-derived M1 gene expression plasmids for immune electron microscopy (IEM). H5 HA
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gene transfected-293T cells that co-expressed H9N2 virus-derived M1 or H5N1-derived M1
produced VLPs with average diameter of 100 nm, indicating that M1 and HA protein interac-
tion promotes VLP assembly (Fig 4A–4C).
Fig 3. H9N2 virus-derived M1 protein strongly bound HA protein in mammalian cells. (A-B) DF-1 or A549 cells
were infected with rM14:M-H5N1 or rM14:M-H9N2 viruses at an MOI of 1. Confocal microscopy was performed to
detect H5N6 HA and M1 protein localization in cells (green and red fluorescence resulting in a yellow color denote
colocalization). (C) The dynamic colocalization 24 h post-transfection as observed via live imaging of H9N2 virus-
derived eGFP-M1/BFP-HA or H5N1-derived eGFP-M1/BFP-HA transfected A549 cells. Pearson’s coefficients were
analyzed in co-localized volume between eGFP-M1 and BFP-HA located at the membrane in 36-time frames (1-time
frame duration = 42.62 s). (D–E) Physical interaction of viral M1 and HA proteins in cells. (D) DF-1 or (E) A549 cells
separately infected with rM14:M-H5N1 and rM14:M-H9N2 viruses at an MOI of 1. At 24 hpi, cell lysates were
immunoprecipitated using anti-M1 antibody or anti-IgG antibody, followed by Western blotting for influenza M1 and
HA proteins. In A549 cells, an increased binding ability was observed between H9N2-derived M1 and HA proteins
than between H5N1-derived M1 and HA proteins. IB, immunoblot. (F–H) interaction between influenza HA and M1
protein was determined by proximity ligation assay. 293T cells were co-transfected with (F) H5 HA and H5N1-derived
M1, (G) H5 HA and H9N2-derived M1, (H) H3 HA and H3N2-derived M1, or (I) empty vector as negative control
(NC). 24 h post transfection, PLA was performed using antibodies specific to influenza M1 and HA proteins.
Fluorescence of cells was analyzed by a fluorescence confocal microscope (red fluorescent signal). Nuclei were stained
with DAPI (blue). (J) Multiple images (F–I) were processed by BlobFinder software to measure the PLA fluorescence
intensity (~30 cells total for each condition). Graphs show the means ± SD of three independent experiments (�,
P< 0.05; ��, P< 0.01).
https://doi.org/10.1371/journal.ppat.1010098.g003
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To investigate the role of M1 protein in the assembly and release of influenza viral particles,
we performed Nano-Flow cytometry (NanoFCM) to quantify the secreted H5N1-derived
eGFP-M1+ or H9N2-derived eGFP-M1+ VLPs. NanoFCM enables detection of extracellular
vesicles (EVs) with a minimum diameter of 40 nm[36–38]. The main peak sizes of eGFP-M1+
particles of both groups were approximately 100 nm, similar in size to the diameter of influ-
enza particles observed in IEM (Fig 4D and 4E). The percentage of H5N1-derived eGFP-M1+
particles was 4.7% (Fig 4G), whereas that of H9N2-derived eGFP-M1+ particles was signifi-
cantly higher (7.6%, P< 0.001) (Fig 4H). Only 0.8% of VLPs from empty vector expressing
cells (used as negative control) were eGFP positive (Fig 4F and 4I). These results demonstrate
that the interaction of H9N2 virus-derived M1, rather than H5N1 virus-derived M1, with HA
protein is more conducive to the release of influenza VLPs.
Human GNB1 protein exhibited enhanced binding to H9N2 virus-derived
M1 protein
Influenza virions contain host proteins that shape virion architecture during budding[39,40].
Liquid chromatography-mass spectrometry (LC-MS) analysis of H9N2 virus-derived M1 com-
plexes identified 154 host proteins that interact with M1 protein (S4A Fig and S3 Table). Using
an exponentially modified protein abundance index (emPAI) (� 0.4), 28 candidate interacting
Fig 4. H9N2 virus-derived M1 protein increased viral progeny particle release in mammalian cells. (A–C) IEM
analysis of influenza VLPs in the concentrated cell culture supernatant. 293T cells were co-transfected with (A) HA
and H5N1-derived M1, (B) HA and H9N2-derived M1, or (C) empty vector as negative control. Anti-H5N1 IAV HA
antibody was used as the primary antibody. The gold is 10 nm in diameter. (D–I) Size and molecular profiling of
eGFP-M1+ VLP particles via a Flow NanoAnalyzer. 293T cells were co-transfected with (D, G) HA and H5N1-derived
eGFP-M1, (E, H) HA and H9N2-derived eGFP-M1, or (F, I) empty vector as negative control. eGFP was used to label
the VLPs. Size profiling of the purified eGFP-M1+ VLP particles with the FITC channel, where Y-axis represents the
events, and X-axis represents the size. (G–I) Molecular profiling of eGFP-M1+ VLP particles. SS-A, side scatter area.
https://doi.org/10.1371/journal.ppat.1010098.g004
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proteins were shortlisted from the 154 interacting proteins (S4A Fig). Four candidate interact-
ing proteins, karyopherin subunit beta 1 (KPNB1), junction plakoglobin (JUP), cleft lip and
palate transmembrane protein 1 (CLPTM1), and GNB1 were further shortlisted with Co-IP
assays. These four candidate proteins are connected to the budding process mediated by M1
protein during viral cycle and associated with secretion or transport function[40–44]. Both
H9N2- and H5N1-derived M1 proteins specifically bound GNB1; however, H9N2 virus-
derived M1 and GNB1 proteins exhibited stronger binding affinity (S4B Fig). However, inter-
action between H9N2 virus-derived M1 protein with the other three candidate proteins was
not evident (S4B Fig).
To further demonstrate the interaction between H9N2- or H5N1-derived M1 and GNB1 pro-
teins, we performed PLA in 293T cells. Interaction between H3N2-derived M1 and GNB1 proteins
was detected as control (Fig 5). Weak PLA signals were found in cells transfected with H5N1-der-
ived M1 expression plasmid at 24 h post-transfection; in contrast, PLA fluorescence intensity was
significantly higher in cells transfected with H3N2-derived M1 (P< 0.05) or H9N2-derived M1
(P< 0.01) (Fig 5). These results indicate that H3N2-derived M1 and H9N2-derived M1 exhibit
stronger interaction than H5N1-derived M1 with human GNB1. Therefore, GNB1 is a specific
and high affinity protein-binding partner of H9N2 virus-derived M1.
GNB1 protein facilitated transport of H9N2 virus-derived M1 protein and
VLP assembly
M1 protein is directed to the apical budding site via its association with HA in lipid rafts[45].
To assess the role of GNB1 and M1 protein interaction in transport capacity of M1 protein, we
performed live imaging to observe the dynamics of M1, HA, and GNB1 proteins in A549 cells.
The localization of eGFP-M1, BFP-HA, and mCherry-GNB1 in A549 cells was ascertained to
determine whether GNB1 protein specifically co-localized with M1 protein in the cell
Fig 5. GNB1 protein bound more strongly to H9N2 virus-derived M1 protein than to H5N1-derived M1 protein.
(A–D) Interaction between influenza M1 and endogenous GNB1 proteins was determined by PLA. 293T cells were
transfected with (A) H5N1-derived M1 plasmid, (B) H9N2-derived M1 plasmid, (C) H3N2-derived M1 plasmid, or
(D) empty vector as negative control. The PLA was performed using antibodies specific to influenza M1 and
endogenous GNB1 proteins. The fluorescence of cells was analyzed by a fluorescence confocal microscope (red
fluorescent signal). Nuclei were stained with DAPI (blue). (E) Multiple images (A–D) were processed by BlobFinder to
measure the PLA fluorescence intensity per cell (~30 cells total for each condition). Graphs show means ± SD of three
independent experiments (�, P< 0.05; ��, P< 0.01).
https://doi.org/10.1371/journal.ppat.1010098.g005
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membrane during viral budding. H9N2 virus-derived eGFP-M1, but not H5N1-derived
eGFP-M1, extensively co-localized with mCherry-GNB1 (combined green and red
fluorescence = yellow color) (Fig 6A). In one stack, the mCherry-GNB1 intensity profile distri-
bution was different from that of H5N1-derived eGFP-M1 and BFP-HA; the latter interaction
was scattered diffusely in the cytoplasm without specific accumulation in the cell membrane
(Fig 6B and 6C). mCherry-GNB1 specifically accumulated at the cell membrane with intensity
profiles similar to those of H9N2 virus-derived eGFP-M1 and BFP-HA (Fig 6B and 6D).
Fig 6. mCherry-GNB1 specifically co-localized with H9N2 virus-derived eGFP-M1 protein. (A–B) Visualization of
the single-channel images showing the localization of BFP-HA (blue), eGFP-M1 (green), and mCherry-GNB1 (red) in
A549 cells, measured after co-transfecting H9N2-derived eGFP-M1/BFP-HA/mCherry-GNB1 or H5N1-derived
eGFP-M1/BFP-HA/mCherry-GNB1 in (A) 3D projection or (B) one stack (Z-start: 0.0 μm, Z-end: 50.0 μm, Z-step:
0.5000 μm) using line profiles in image-analysis software platform Fiji. (C–D) The fluorescence intensity profile was
plotted along the white arrow crossing the cell membrane in Fig 6B using ImageJ/Fiji software. The signal intensities
(absolute gray values from 16-bit raw images) are plotted, where Y-axis shows the signal intensity, and X-axis shows
the length of the line. The line profiles from three different channels are merged into one graph. Two different
expression patterns are shown, highlighting the differences in the mCherry-GNB1 (red) and the similarities in the
BFP-HA (blue) and eGFP-M1 (green) signal. Scale bars: 2 μm.
https://doi.org/10.1371/journal.ppat.1010098.g006
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Transfection of tagged viral and host proteins enables visualization of co-transport of virus
protein and host component[46,47]. To further examine the dynamics of viral M1 and human
GNB1 proteins, we performed live imaging of A549 cells transfected with eGFP-M1 (H9N2- or
H5N1-derived M1), BFP-HA, and mCherry-GNB1. The corresponding overlap of the three sig-
nals indicates similar trajectories (Fig 7A), and positional relationship (Fig 7B) between
eGFP-M1, BFP-HA, and mCherry-GNB1 within the cell (S1 Movie). The speed of mCherry-
GNB1 and eGFP-M1 proteins in H9N2 virus-derived eGFP-M1/BFP-HA/mCherry-GNB1
transfected cells showed similar distribution with approximately equal means, which were sig-
nificantly higher than that in H5N1-derived eGFP-M1/BFP-HA/mCherry-GNB1 transfected
cells (P< 0.001) (Fig 7C); this suggests that GNB1 facilitates the transport of H9N2 virus-
derived M1. Furthermore, our results showed that both H9N2-derived M1 triggered VLPs and
H5N1-derived M1 triggered VLPs could bud from the plasma membrane where mCherry-
GNB1, BFP-HA, and eGFP-M1 clustered. However, more H9N2-derived M1 triggered VLPs
accumulated at the plasma membrane (S5 Fig), suggesting that GNB1 assists the transport of
H9N2 virus-derived M1 and assembly of the influenza VLPs. To further confirm this finding,
we performed IEM. As shown in Fig 7D, GNB1 was detected in influenza virions. These results
indicate that specific interaction between the H9N2 virus-derived M1 protein and the human
GNB1 protein promotes transport of M1 protein to the cell membrane in mammalian cells,
which in turn facilitates the binding of M1 and HA, and enhances the budding of H5N6 viral
particles (a proposed model is shown in Fig 7E).
GNB1 protein contributed to viral particle release triggered by H9N2 virus-
derived M1 protein
To determine whether GNB1 in assisting transport of H9N2 virus-derived M1 protein to the
cell membrane could influence budding of VLPs, we knocked down the expression of GNB1
gene in A549 cells by transfection with #297 siRNA to monitor the interaction between HA
and M1 proteins. GNB1 knockdown decreased binding between H9N2 virus-derived M1 and
HA proteins in Co-IP assays (Fig 8A). The interaction between M1 and GNB1 proteins was
determined by PLA in A549 cells. In GNB1-knockdown cells transfected with H9N2 virus-
derived M1 and HA, fluorescence intensity of PLA signals was significantly reduced
(P< 0.001) (Fig 8B–8E). Collectively, these results confirm that GNB1 protein promotes the
interaction of H9N2 virus-derived M1 and HA proteins in mammalian cells.
To investigate the role of GNB1 in the assembly and release of influenza viral particles,
293T cells (with and without GNB1 knockdown) were transfected with H9N2 virus-derived
eGFP-M1 and HA gene (Fig 9A). NanoFCM were performed to quantify the secreted H9N2
virus-derived eGFP-M1+ EVs. The main peak size of EVs of H9N2 virus-derived eGFP-M1+
particles was approximately 100 nm (Fig 9B). The percentage of H9N2 virus-derived
eGFP-M1+ particles in the NC siRNA-transfected group was 4.0% (Fig 9D), whereas H9N2
virus-derived eGFP-M1+ particles in the GNB1-silenced group was 0.9% (Fig 9C and 9E).
These results demonstrate that GNB1 knockdown reduces the release of influenza VLPs.
To assess whether GNB1 affects viral replication, GNB1-knockdown A549 cells (Fig 9F)
were separately infected with rM14:M-H5N1 and rM14:M-H9N2 virus (at MOI of 1.0). GNB1
knockdown significantly decreased virus titers of rM14:M-H9N2 at 6, 12 and 24 hpi (P< 0.01)
(Fig 9H), and inhibited the expression of viral HA and M1 proteins in a time-dependent man-
ner at 6, 12 and 24 hpi (Fig 9J). However, GNB1 knockdown did not affect the rM14:M-H5N1
virus replication in A549 cells (Fig 9G and 9I). Collectively, these data suggest that GNB1 is
intimately involved in the replication cycle of H5N6 virus that encodes H9N2 virus-derived
M1 protein.
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Fig 7. GNB1 protein co-transported with M1 protein in A549 cells. (A) A549 cells were transfected with eGFP-M1,
BFP-HA, and mCherry-GNB1 expression plasmids. Cross-section through the volume depicts the signal from the three
channels. Yellow arrowheads indicate the co-localized puncta corresponding to co-transport of eGFP-M1 and
mCherry-GNB1 to BFP-HA (S1 Movie). The blue, green, and red arrows or balls represent the tracks or punctas of
BFP-HA, eGFP-M1, and mCherry-GNB1, respectively. (B) Enlarged view of the combination of H9N2-derived
eGFP-M1, BFP-HA, and mCherry-GNB1. (C) Live-cell imaging illustrating the dynamic movement of the fluorescent
fusion protein puncta within a cell with a similar number of spots and tracks between H9N2-derived eGFP-M1/
BFP-HA/mCherry-GNB1 and H5N1-derived eGFP-M1/BFP-HA/mCherry-GNB1 transfected cells, which quantifies the
track speed (ratio of track length to track duration [μm/s]) to characterize the intracellular movement. Each datapoint
represents a punctum from the corresponding channel for the motion parameters (track speed) of eGFP-M1 singletons
and mCherry-GNB1 singletons. “1” and “2” denote the speed of mCherry-GNB1 and H9N2-derived eGFP-M1 in
H9N2-derived eGFP-M1/BFP-HA/mCherry-GNB1, respectively. “3” and “4” denote the speed of mCherry-GNB1 and
H5N1-derived eGFP-M1 in H5N1-derived eGFP-M1/BFP-HA/mCherry-GNB1, respectively. (D) IEM analysis of
influenza virus in the supernatant from infected cells. A549 cells were infected with rM14:M-H9N2 virus at an MOI of
1. At 24 hpi, supernatants from infected cells were collected for IEM. Anti-GNB1 or anti-influenza M1 antibody were
used as the primary antibody. The gold is 10 nm in diameter. (E) Proposed model of the roles of GNB1 in viral
assembly and budding of influenza VLPs.
https://doi.org/10.1371/journal.ppat.1010098.g007
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Discussion
H9N2 AIVs are a major threat to human public health by acting as donors of viral genes
through reassortment with co-circulating influenza viruses. Here, we demonstrated that H9N2
virus-derived M1, but not H5N1 virus-derived M1, enhances interaction with human host fac-
tor GNB1, to promote M1 transport to the cell membrane which, in turn, facilitates the inter-
action between M1 and HA proteins, ultimately improving viral assembly and release. Our
Fig 8. GNB1 facilitated interaction between M1 and HA proteins in mammalian cells. (A) A549 cells were
transfected with NC siRNA or #297 siRNA and infected with recombinant H5N6 virus (rM14:M-H5N1 or rM14:
M-H9N2). At 24 hpi, cell lysates were immunoprecipitated using an anti-influenza M1 antibody and probed with an
anti-influenza HA antibody. Cell lysates of infected A549 cells were immunoprecipitated using an anti-IgG antibody
and probed with an anti-influenza HA antibody as negative control. Compared to the normal cells, the interaction
between H9N2-derived M1 and HA proteins was decreased in the GNB1-silenced cells. IB, immunoblot. (B–D)
Influenza M1 and HA proteins interaction was determined by PLA. The PLA was performed using antibodies specific
to influenza M1 and HA proteins. The fluorescence of cells was analyzed by a fluorescence confocal microscope (red
fluorescent signal). Nuclei were stained with DAPI (blue). (B) PLA of the cells transfected with NC siRNA and an
empty vector. (C) PLA of the cells transfected with NC siRNA, HA, and H9N2- or H5N1-derived M1 encoding
plasmids. (D) PLA of the cells transfected with #297 siRNA, HA, and H9N2- or H5N1-derived M1 encoding plasmids.
(E) Multiple images (B–D) were processed by BlobFinder to measure the PLA fluorescence intensity per cell (~30 cells
total for each condition). The graphs show the means ± SD of three independent experiments normalized to the HA
+H9N2-derived M1 (NC siRNA) PLA signal. (���, P< 0.001; ns, no significance.)
https://doi.org/10.1371/journal.ppat.1010098.g008
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Fig 9. GNB1 protein contributed to viral particle release triggered by H9N2 virus-derived M1 protein. (A–E)
Sizing and molecular profiling of VLP-associated H9N2-derived eGFP-M1 in #297 siRNA-induced GNB1-silenced or
normal 293T cells. (A) A549 cells were transfected with siRNAs (targeting GNB1 or negative control), and GNB1
protein expression level at 36 h post-transfection were determined by Western blotting. (B–C) Size profiling of
H9N2-derived eGFP-M1+ VLP particles with the FITC channel. (D–E) Molecular profiling of H9N2-derived
eGFP-M1+ VLP particles. SS-H, side scatter height. (F–J) GNB1 knockdown decreased rM14:M-H9N2 virus
replication in A549 cells. (F) GNB1 protein expression level at 36 h post-transfection determined by Western blotting.
A549 cells transfected with siRNAs (either NC or GNB1-targeting siRNA #297) were infected with (G) rM14:M-H5N1
virus or (H) rM14:M-H9N2 virus at an MOI of 1. Viral titers were measured by TCID50 assay at the indicated time
points. Each data is represented as means ± SD and represents three independent experiments. (��, P< 0.01; ���,
P< 0.001; ns, no significance). A549 cells transfected with NC or GNB1-targeting siRNA #297 were infected with (I)
rM14:M-H5N1 virus or(J) rM14:M-H9N2 virus at an MOI of 1, and expression of HA and M1 protein was measured
by Western blotting.
https://doi.org/10.1371/journal.ppat.1010098.g009
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results suggest that H9N2 virus-derived M1 protein, along with surface HA, is key to increased
incidence of H5N6 influenza virus infection in humans.
H9N2 and H5Ny AIVs have been circulating throughout the world, causing substantial eco-
nomic losses to the poultry industry. In particular, these virus subtypes have been shown to
infect humans[5,48]. A systematic review reported seroprevalence to H9N2 virus at 1–43% in
avian-exposed human populations[49], and the seroprevalence of H9N2 antibodies in poultry
workers in China was reported at 11.2%[50], suggesting significant infectivity of H9N2 AIVs in
humans. Notably, H9N2 AIVs are regarded as “enablers” because they can donate their internal
genes through reassortment to produce novel reassortants with higher human infectivity[7–12].
Given that the replacement with the G1-like M gene is a critical change in generating the G57
genotype of H9N2 influenza viruses[22], we focused on the contribution of the H9N2 virus-
derived M gene to the replication of H5N6 virus in mammalian (human) cells. Influenza virus
assembly postulate a direct interaction between the viral matrix protein M1 and the cytoplasmic
domains of the envelope glycoproteins HA and/or NA as a driving force for virus assembly[23].
However, such an interaction has never been demonstrated biochemically. Here, we found that
the H5N6 virus harboring the H9N2 virus-derived M gene, but not the H5N1-derived M gene,
conferred higher binding affinity between M1 and HA proteins, which leads to increased bud-
ding of viral progeny in mammalian cells. Although we identify that C-terminal region of M1
protein is a key functional domain affecting the interaction with HA protein, further study is
needed to determine the exact interaction sites that affect virus budding.
Multiple host proteins are involved in the assembly and budding of influenza virions and
form part of a progeny particle[39,40]. GNB1 is the beta subunit of the family of G proteins,
involved in regulating transmembrane signal transduction[51]. G proteins can be transferred
between cells and are involved in apical versus basolateral transport in polarized epithelial
cells, such as the apical transport of HA protein in virus-infected MDCK cells[52,53]. Initiation
of virus budding may involve processes similar to membrane ruffling that are affected by cyto-
skeletal components, lipid rafts and signal transduction mediated by G proteins[54]. Thus, G
protein-targeting drugs could conceivably inhibit virus budding[44]. It is believed that G pro-
teins participate in the replication cycle of AIVs, wherein viral proteins interact directly or
indirectly with G proteins[44,55,56]. However, the precise role of the G protein in influenza
virus budding hitherto has remained unclear[44]. Here, we demonstrated that GNB1 promotes
the interaction of influenza HA and M1 proteins during viral assembly to enhance progeny
virus release.
Most studies to date have focused on the nucleocytoplasmic shuttling of vRNP, whilst only
a few studies have investigated the transport of viral proteins to the plasma membrane[47]. In
our study, using live-cell imaging, we found that host GNB1, in specific concert with H9N2
virus-derived M1, exerts a boosting effect on virus budding, which involves GNB1 binding of
M1 and directing it to the viral assembly and budding site at the cell membrane. This mecha-
nism would account in part for H9N2 virus-derived internal genes to be highly represented in
human-derived avian H5N6 viruses. Our results reveal a key mechanism underlying AIVs
infection in humans and provide a theoretical basis for a novel host-based antiviral target.
Materials and methods
Phylogenetic analyses
All available gene sequences of H5N6 AIVs in China were downloaded from the NCBI Influ-
enza Virus Database (https://www.ncbi.nlm.nih.gov/genomes/FLU/) and the GISAID (https://
www.gisaid.org/). RAxML V. 8.2.12 was used to construct maximum likelihood phylogenies
for each gene segment[33] via the CIPRES Science Gateway V. 3.3[57]. One thousand
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bootstrap replicates were run, and GTRGAMMA + I was used as the nucleotide substitution
model. Each internal gene was classified based on the evolutionary lineage. Based on phyloge-
netic analyses, the internal genes of H5N6 viruses were classified into different lineages accord-
ing to the tree topology and bootstrap values (> 70).
Cells and viruses
293T cells, Calu-3 cells, A549 cells, MDCK cells and DF-1 cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS;
Gibco), 100 units/mL penicillin and 100 μg/mL streptomycin. All cells were cultured at 37˚C
in a humidified incubator with 5% CO2.
Clade 2.3.4.4 H5N6 HPAIV A/goose/Northern China/M14/2016 (M14) and A/goose/
Northern China/M10/2016 (M10) and H3N2 human seasonal virus A/Kansas/14/2017 were
propagated in 9 days SPF embryonated chicken eggs and stored at -80˚C. M14 and M10 house
the H9N2 virus-derived M gene and the H5N1-derived M gene, respectively. All experiments
with H5 subtype viruses were performed in a biosafety level 3 containment.
Generation of recombinant H5N6 viruses
All eight gene segments of the M14 virus (H9N2 virus-derived M gene) and the M gene of
M10 (H5N1-derived M gene), amplified by reverse transcription-PCR (RT-PCR), were indi-
vidually cloned into a dual-promoter plasmid pHW2000, as described previously[58]. The
reverse genetic virus rM14:M-H9N2, carrying all eight genes from the M14 virus, and the reas-
sortant virus rM14:M-H5N1, with the M gene from the M10 virus and the remaining seven
genes from the M14 virus, were generated by reverse genetics in 293T cells. All viruses were
propagated in 9-day-old SPF chicken embryos and sequences were verified before use.
Virus titration and replication kinetics
TCID50 was determined in MDCK cells infected with 10-fold serially diluted viruses and cul-
tured at 37˚C in a 5% CO2 atmosphere for 48 h. Virus infected cells were examined by detec-
tion of viral NP using immunofluorescence. TCID50 value was calculated using the Reed-
Muench method[59]. Multistep replication kinetics were determined by inoculating DF-1,
MDCK, A549 and Calu-3 cells with viruses at an MOI of 0.01. Following 1 h incubation at
37˚C, the cells were washed three times and incubated in serum-free DMEM. Supernatants
were collected at 6, 12, 24, 36, 48, 60 and 72 hpi and titrated on MDCK cells. Each experiment
was conducted three times, and each experiment was performed in triplicate.
Antibodies and reagents
Anti-IAV M1 antibody was kindly provided by Prof. Wenjun Liu, Chinese Academy of Sci-
ences. Anti-H5N1 IAV HA antibody (11689-T54) was from Sino Biological. Anti-GNB1 anti-
body (10247-2-AP) was from Proteintech. Anti-β-actin antibody was from Beyotime. Anti-
IAV NP antibody (ab20343) and anti-karyopherin subunit beta 1 antibody (KPNB1, ab2811)
were from Abcam. Anti-junction plakoglobin antibody (JUP, 2309) was from CST, anti-cleft
lip and palate transmembrane protein 1 antibody (CLPTM1, sc-374619) was from Santa
Technology.
Colocalization detection by confocal microscope
DF-1 and A549 cells were infected with indicated viruses at an MOI of 1. Cells were fixed with
4% paraformaldehyde in phosphate-buffered saline (PBS) for 30 min and permeabilized with
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immunostaining permeabilization buffer with Triton X-100 (Beyotime) for 10 min. After
blocking with 5% BSA in PBS, anti-IAV M1 or anti-H5N1 IAV HA antibodies were used to
detect M1 or HA proteins. Next, the cells were washed three times with PBS and incubated
with fluorescein isothiocyanate (FITC; KPL) or tetramethyl rhodamine isothiocyanate
(TRITC; KPL) labeled secondary antibodies for 1 h at 37˚C. Subsequently, the cells were
washed three times with PBST, and images were acquired using Nikon A1 confocal micro-
scope (Nikon).
Western blotting
Western blotting was performed as previously described[60]. Briefly, cell lysates were prepared
from transfected cells using radioimmunoprecipitation assay (RIPA) lysis buffer, heated at
100˚C for 10 min and were separated by 10% sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis. After electrophoresis, protein samples were electroblotted onto polyvinylidene
difluoride (PVDF) membranes (Bio-Rad) and blocked for 2 h in Tris-buffered saline (10 mM
Tris-HCl, pH 8.0, containing 150 mM NaCl) containing 5% (w/v) non-fat dry milk and 0.5‰
(v/v) Tween-20. The membranes were incubated with the primary antibodies overnight at
4˚C, followed by incubated with corresponding horseradish peroxidase (HRP)-conjugated sec-
ondary antibodies for 1 h at room temperature. The presence of HRP was detected by using a
Western Lightning chemiluminescence kit (Amersham, USA) according to the manufacturer’s
protocol.
Co-IP
For the Co-IP assays, cells were infected with the recombinant H5N6 virus (rM14:M-H5N1 or
rM14:M-H9N2) at an MOI of 1. After 24 hpi, cells were washed with PBS and lysed in 450 μL
cell lysis buffer for Western and IP containing protease and phosphatase inhibitors (Roche
Life Science), and protein lysates were used for Co-IP. Lysates were incubated with anti-IAV
M1 antibody overnight at 4˚C, and then protein A/G agarose beads (Santa Cruz Biotechnol-
ogy) were added to the samples for 3–4 h at 4˚C. The beads were washed four times with cold
lysis buffer and analyzed by Western blotting.
In situ PLA microscopy
A DuoLink PLA kit (DUO92105-1KT, Sigma) was used to detect protein-protein interactions
as described in the protocol. Briefly, cells were fixed, permeabilized, and incubated with corre-
sponding primary antibodies diluted in DuoLink dilution buffer. After incubation with primary
antibodies, cells were incubated with PLA probes at 37˚C for 1 h, followed by 30 min ligation at
37˚C, and 100 min amplification at 37˚C. Finally, a detection solution consisting of fluores-
cently labeled oligonucleotides was added, and the labelled oligonucleotides were hybridized to
the concatemeric products. Nuclei were stained with DAPI. The fluorescence of cells was ana-
lyzed by a fluorescence confocal microscope (SP8 Lightning; Leica Microsystems).
Images obtained from PLA experiments were processed using BlobFinder, which performs
single-cell analysis and quantifies the fluorescence signal intensity per cell for each sample[61].
The signal intensity of at least 30 cells was averaged in each experiment. Additionally, the rela-
tive fluorescence intensity of three independent experiments was averaged and plotted.
Bimolecular fluorescence complementation (BiFC)
For the construction of BiFC plasmids, the complementary DNAs (cDNAs) of M1 and HA
were amplified by PCR. Sequences encoding the amino [residues 1–173 (VN)] of the Venus
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fluorescence protein were fused to the HA of H5N6 virus M14 which were designated as
VN-HA-M14. The carboxyl [residues 155–228 (VC)] fragments of the Venus fluorescence
protein were fused to the total M1 of M14 termed VC-M1-M14. The VC fragments fused to
the truncated M1 protein (containing either 1–87, 88–164 or 165–252 residues) of M14 were
designated as VC-M1N-M14, VC-M1M-M14 and VC-M1C-M14, respectively. Each full-
length or truncated VC-M1 plasmid was co-transfected with VN-HA-M14 into 293T cells. 24
h post-transfection, the fluorescence signals were analyzed.
IEM
For IEM, the supernatant from transfected or infected cells were centrifuged at 300 ×g for 10
min at 4˚C to remove cells and 10,000 ×g for 30 min to remove debris. Supernatant were ultra-
centrifuged at 120,000 ×g for 70 min. The precipitant was re-suspended in PBS, loaded onto a
30–60% sucrose density gradient, and centrifuged at 150,000 ×g in an SW40 rotor (Beckman)
for 22 h at 4˚C. After ultracentrifugation, the 30–45% sucrose density gradient was extracted
and centrifuged at 120,000 ×g for 70 min at 4˚C. The precipitant re-suspended in PBS was pro-
cessed further. Aliquots were adsorbed onto the carbon-coated copper grids and stained with
2% phosphotungstic acid (pH 7.2) for 120 s.
For immunogold labeling, the grids were incubated sequentially with blocking solution (1%
BSA and 0.15% glycine in PBS), primary antibody diluted in the blocking solution, and
immune-gold conjugate electron microscope goat anti-rabbit IgG H&L (10 nm gold; Abcam)
or goat anti-mouse IgG H&L (10 nm gold; Boster Biological Technology) diluted in blocking
solution, for 1 h each, and then washed with blocking solution. The grids were fixed with 2.5%
glutaraldehyde for 5 min and stained with 2% uranyl acetate (for VLPs on the cell surface) or
2% phosphotungstic acid (for VLPs in the supernatant). Finally, the samples were examined in
an HT-7800 electron microscope at 80 kV (Hitachi).
Sizing and molecular profiling of individual EVs
To investigate the role of M1 protein (of different origins) in assembly and release of influenza viral
particles, we fused H9N2- or H5N1-derived M1 to eGFP-tagged expression plasmid
(pCMV-C-EGFP, Beyotime), and fused influenza HA to the pRK5 plasmid by homologous recom-
bination. eGFP-M1-loaded VLPs were assessed from expression of HA and eGFP-M1 (H9N2- or
H5N1-derived M1) proteins in 293T cells. Cells were cultured in DMEM containing 10% serum in
a 10 cm dish and grown to 80% confluence. The culture supernatant was removed and washed
twice with PBS before the addition of Opti-MEM (Gibco). The culture supernatant was harvested
at 24 h post-transfection for EVs purification. The supernatant was differentially centrifuged at
300, 2,000, 10,000 and 100,000 ×g for 10, 20, 30 and 17 min, respectively. For each centrifugation,
the pellets were washed once with PBS and centrifuged again. The 100,000 ×g ultracentrifugation
was performed using TLA120.2 (Beckman) and Superspin 630/17 (Thermo Scientific) at 4˚C.
The size distribution analysis assumes that the sample has a comparable refractive index
with the silica nanoparticles. The Silica Nanospheres Cocktail (S16M-Exo) is used as the size
standard, and a calibration curve is constructed based on the sizes of the particles in
S16M-Exo and their side scattering intensities. Using this calibration curve, every single parti-
cle side scattering intensity is converted into the corresponding particle size.
By setting a fixed number of events, samples were collected and analyzed for the fluores-
cence intensity of eGFP-M1+ particles. The pellet obtained after ultracentrifugation at 100,000
×g for 17 min at 4˚C was re-suspended in 100 μL PBS for further analysis with a Flow NanoA-
nalyzer model type N30E (NanoFCM) equipped with a laser (488 nm) and two channels (SSC,
FITC channel).
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Mass spectrometry assays
A549 cells were infected with rM14:M-H9N2 virus (MOI of 1) for 24 h. Cell lysates were then
harvested from infected cells using cell lysis buffer for Western blotting and IP (Beyotime).
Next, H9N2 virus-derived M1 complexes in the cell lysates were purified using an anti-M1
antibody and analyzed by LC-MS. IgG immunoprecipitants from rM14:M-H9N2-infected
samples were used as negative control in LC-MS analysis. Proteins identified in the M1 immu-
noprecipitants, but not in the IgG immunoprecipitants, were considered as M1-interacting
proteins.
LiTone LBS light-sheet imaging
To examine the colocalization dynamics between the viral M1 and HA proteins in the plasma
membrane of A549 cells, observations were made on H9N2 virus-derived eGFP-M1/BFP-HA
and H5N1 virus-derived eGFP-M1/BFP-HA transfected A549 cells at 24 h post-transfection.
The plasma membrane was labeled with CellMask Plasma Membrane 647. Pearson’s coeffi-
cients were analyzed in colocalized volume between eGFP-M1 and BFP-HA located at the
membrane in 36-time frames (1-time frame duration = 42.62 s). Light sheet imaging data were
acquired in XYCZT order and have enough intensity dynamic range with higher bit depth (16
bit). The spatial resolution of each channel is 250 nm (X axis) � 250 nm (Y axis) � 350 nm (Z
axis) which would be improved to half numerical of all directions by deconvolution. For colo-
calization analysis, we transform tiff format into ims. file to use ImarisColoc, which is a quanti-
fication tool based on voxels.
To investigate the colocalization of GNB1, influenza HA and M1 proteins during intracellu-
lar transport in mammalian cells, we fused H9N2- or H5N1-derived M1 to the eGFP-tagged
expression plasmid (pCMV-C-EGFP, Beyotime), influenza HA to the BFP-tagged expression
plasmid (pCMV-C-BFP, Beyotime), and GNB1 to the mCherry-tagged expression plasmid
(pCMV-C-mCherry, Beyotime) by homologous recombination. A549 cells were transfected
with BFP-HA, mCherry-GNB1, and eGFP-M1 (H9N2- or H5N1-derived M1), carrying plas-
mids and seeded on 5 mm round glass coverslips (105 cells) for high-resolution live imaging
using light-sheet microscopy. The coverslips were cleaned using 75% ethanol and UV radiated
before seeding. Before imaging, cells on the coverslip were stained with Cell Mask Plasma
Membrane 647 (Invitrogen) for 15 min and washed by PBS twice. DMEM (15 mL) with 20
mM HEPES lacking phenol red was pre-heated to 37˚C and placed in the imaging chamber.
Three-dimensional (3D) live-cell imaging was performed on a high-resolution light-sheet
microscope (LiTone LBS Light-sheet Microscope; Light Innovation Technology) with a 350
nm ultra-thin beam aligned in advance. Coverslips seeded with cells were clamped on the sam-
ple holder and immediately inserted into the pre-heated imaging chamber filled with DMEM
and stabilized at 37˚C. The regions of interest were targeted in EPI fluorescence mode with a
10× objective lens, and captured in LBS mode using 25× water immersion objective lens
(Nikon CFI75 25XW, N.A. = 1.1) and a 2.5 magnification zoom module with minimum laser
excitations at 405, 488, 561, and 647 nm, respectively. Real-time protein dynamics were
recorded as a time-lapse of z-stacks with 250 nm step-size for 4 h at 50-time points. The decon-
volution (using a modified Richardson–Lucy deconvolution algorithm) and final 3D movies
were generated using the 3D projection function provided by LitScan 2.0.2 software. To exam-
ine the co-transport of influenza M1, influenza HA, and GNB1, A549 cells were transfected
with eGFP-M1, BFP-HA, and mCherry-GNB1 and stained the cells with Cell Mask Plasma
Membrane 647 (Invitrogen). Next, we performed four-color volumetric, live imaging of the
fluorescent fusion protein transport mode within the same cell using the LBS Light-sheet and
tracked eGFP-M1, BFP-HA, and mCherry-GNB1. The tracking workflow was developed by
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analyzing and distilling track data derived from 3D images. The LBS Light-sheet datasets fea-
ture isotropic resolution (< 350 nm) obtained at ~0.025 Hz volumetric temporal resolution to
capture fast-moving molecules. The H9N2-derived eGFP-M1, BFP-HA, and mCherry-GNB1
channels overlap at a single time point for the same dataset. Spheres of corresponding colors
depicted colocalized puncta from each species at that time point, while arrowheads of corre-
sponding colors depicted their tracks over all time points. Significant co-transport between
colocalized puncta was observed due to the proximity between individual track segments trav-
eling along the same direction.
siRNA-mediated gene knockdown
To knock down the indicated target gene GNB1, the chemically synthesized siRNA and nega-
tive control (NC) siRNA were obtained from GenePharma Company. NC means negative con-
trol showing a negative or null effect in GNB1 protein knockdown. A549 cells were transfected
with 50 nM siRNA using 3μL Lipofectamine RNAiMAX (Invitrogen) for approximately 36 h,
and then used for the subsequent analyses.
Statistical analyses
All statistical analyses were performed using Prism V. 8.0.2 (GraphPad Software). Statistical
significance was assessed using Student’s t-test, one-way ANOVA followed by a Dunnett post-
hoc test, or Chi-square test. P< 0.05 was considered to indicate a statistically significant
difference.
Accession number(s)
The nucleotide sequences of the eight gene segments of influenza viruses of M14 and M gene
of M10 are available from GenBank under accession numbers MW774363-MW774371.
Supporting information
S1 Fig. Phylogenetic trees for the HA, NA, PB2, PB1, PA, NP, M and NS genes of influenza
viruses related to Fig 1. Phylogenetic trees were estimated using genetic distances calculated
by maximum likelihood under the GTRGAMMA + I model. Scale bar is in units of nucleotide
substitutions per site. Node labels represent bootstrap values. Virus labeled with a red asterisk
were used in the present research.
(PDF)
S2 Fig. Physical interaction of viral M1 and HA proteins in Calu-3 and MDCK cells. Calu-3
or MDCK cells were infected separately with rM14:M-H5N1 and rM14:M-H9N2 at an MOI of
0.01. At 24 hpi, cell lysates were immunoprecipitated with anti-M1 antibody or anti-IgG anti-
body, followed by Western blotting for influenza M1 and HA proteins. An increased binding
ability were observed between H9N2-derived M1 and HA proteins than between H5N1-der-
ived M1 and HA proteins in both Calu-3 and MDCK cells. IB, immunoblot.
(TIF)
S3 Fig. Interaction of truncated H9N2 virus-derived M1 and HA proteins in 293T cells by
BiFC assay. (A) Domain structure of M1 and schematic representation of truncated M1 BiFC
constructs. Schematic diagram of the domain structure of M1 as defined by crystallography
(coordinates are amino acid number) and the subdivisions used in this study. (B) Each trun-
cated M1 plasmid was co-transfected with VN-HA-M14 plasmid into 293T cells. At 24 h post
transfection, 293T cells were taken under the fluorescent microscope and light microscope
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successively. (C) The positive cell rate of 293T cells transfected with BiFC constructs. The posi-
tive cells were determined by the fluorescence signal at different groups after transfection. The
positive cell rate was calculated by counting positive cell numbers in 500 cells at 3 fields. The
values shown are means ± standard deviations of results for three independent experiments.
Statistical significance was based on one-way ANOVA (���, P< 0.001).
(TIF)
S4 Fig. Host protein interacting with H9N2 virus-derived M1 protein in A549 cells. (A)
The Venn diagrams illustrate the number of candidate proteins interacts with M1 protein in
A549 cells. (B) A549 cells were infected with the recombinant H5N6 virus (rM14:M-H5N1 or
rM14:M-H9N2). At 24 hpi, cell lysates were immunoprecipitated with anti-M1 antibody and
probed with anti-KPNB1, anti-JUP, anti-CLPTM1, and anti-GNB1 antibodies. Cell lysates
extracted from infected A549 cells were immunoprecipitated with anti-IgG antibody and
probed with anti-KPNB1, anti-JUP, anti-CLPTM1, and anti-GNB1 antibodies as negative con-
trol. KPNB1, JUP, CLPTM1, and GNB1 did not immunoprecipitate in the absence of M1
immunoprecipitation during virus infection, ruling out any artifacts caused by the anti-M1
antibody. Both H9N2- and H5N1-derived M1 proteins specifically bound to GNB1; however,
H9N2 virus-derived M1 and GNB1 proteins exhibited higher affinity binding.
(TIF)
S5 Fig. Longitudinal section depicts budding of VLPs from H9N2 virus-derived eGFP-M1,
BFP-HA, mCherry-GNB1 and merged channels. The dashed line depicts the cell outline,
while the solid line circle depicts the VLPs budding from the plasma membrane, and the trian-
gle indicates the accumulation of eGFP-M1, BFP-HA, and mCherry-GNB1.
(TIF)
S1 Table. Detailed information of human H5N6 viruses analyzed in this study.
(DOCX)
S2 Table. Sequence identity of the M14 virus compared with human-isolated H5N6 viruses
possessing H9N2-derived internal genes.
(DOCX)
S3 Table. Host protein interacting with H9N2-virus derived M1 protein in mammal cell.
(DOCX)
S1 Movie. Image analysis workflow for spot identification and tracking. Sample dataset for
live-imaging of A549 cells transfected with eGFP-M1, BFP-HA and mCherry-GNB1. For each
time-lapse live-cell imaging dataset, blue, green and red arrows or balls represent the tracks or
punctas of BFP-HA, eGFP-M1 and mCherry-GNB1. The cyan color indicates the cytoplasmic
membrane.
(AVI)
S2 Movie. Budding of VLPs from cell membrane in one stack. A time-lapse sample movie of
numerous VLPs releasing from apical membranes in one stack (Z-start: 0.0 μm, Z-end:




Conceptualization: Juan Pu, Yipeng Sun, Jinhua Liu, Honglei Sun.
PLOS PATHOGENS H9N2 virus-derived M1 protein promotes H5N6 virus human infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1010098 December 3, 2021 20 / 24
Data curation: Fangtao Li, Jiyu Liu, Zhimin Jiang, Chenxi Wang, Chuankuo Zhao, Juan Pu,
Yipeng Sun, Kin-Chow Chang, Jinhua Liu, Honglei Sun.
Formal analysis: Fangtao Li, Jiyu Liu, Zhimin Jiang, Chenxi Wang, Chuankuo Zhao, Juan Pu,
Yipeng Sun, Kin-Chow Chang, Jinhua Liu, Honglei Sun.
Funding acquisition: Yipeng Sun, Jinhua Liu, Honglei Sun.
Methodology: Fangtao Li, Jiyu Liu, Jizhe Yang, Chenxi Wang, Xin Zhang, Yinghui Yu, Hon-
glei Sun.
Project administration: Fangtao Li, Jiyu Liu, Jizhe Yang, Haoran Sun, Xin Zhang, Yinghui
Yu, Honglei Sun.
Writing – original draft: Haoran Sun, Juan Pu, Yipeng Sun, Jinhua Liu, Honglei Sun.
Writing – review & editing: Juan Pu, Yipeng Sun, Kin-Chow Chang, Jinhua Liu, Honglei
Sun.
References
1. WHO. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO.
2021. Available from: https://cdn.who.int/media/docs/default-source/influenza/human-animal-interface-
risk-assessments/2021_aug_tableh5n1.pdf?sfvrsn=12194b1_6&download=true.
2. WHO. Human infection with avian influenza A(H5) viruses. 2021. Available from: https://www.who.int/
docs/default-source/wpro—documents/emergency/surveillance/avian-influenza/ai-20211001.pdf?
sfvrsn=30d65594_167.
3. Quan C, Shi W, Yang Y, Yang Y, Liu X, Xu W, et al. New Threats from H7N9 Influenza Virus: Spread
and Evolution of High- and Low-Pathogenicity Variants with High Genomic Diversity in Wave Five. Jour-
nal of Virology. 2018; 92(11):e00301–18. https://doi.org/10.1128/JVI.00301-18 PMID: 29563296
4. Li X, Shi J, Guo J, Deng G, Zhang Q, Wang J, et al. Genetics, receptor binding property, and transmissi-
bility in mammals of naturally isolated H9N2 Avian Influenza viruses. PLoS pathogens. 2014; 10(11):
e1004508. Epub 2014/11/21. https://doi.org/10.1371/journal.ppat.1004508 PMID: 25411973; PubMed
Central PMCID: PMC4239090.
5. WHO. Monthly risk assessment summary. 2020. Available from: https://www.who.int/influenza/human_
animal_interface/HAI_Risk_Assessment/en/.
6. Peteranderl C, Herold S, Schmoldt C. Human Influenza Virus Infections. Semin Respir Crit Care Med.
2016; 37(4):487–500. Epub 08/03. https://doi.org/10.1055/s-0036-1584801 PMID: 27486731.
7. Hao X, Hu J, Wang X, Gu M, Wang J, Liu D, et al. The PB2 and M genes are critical for the superiority of
genotype S H9N2 virus to genotype H in optimizing viral fitness of H5Nx and H7N9 avian influenza
viruses in mice. Transboundary and Emerging Diseases. 2020; 67(2):758–68. https://doi.org/10.1111/
tbed.13395 PMID: 31631569
8. He J, Liu BY, Gong L, Chen Z, Chen XL, Hou S, et al. Genetic characterization of the first detected
human case of avian influenza A (H5N6) in Anhui Province, East China. Scientific reports. 2018; 8
(1):15282. Epub 2018/10/18. https://doi.org/10.1038/s41598-018-33356-4 PMID: 30327485; PubMed
Central PMCID: PMC6191424.
9. Guan Y, Shortridge KF, Krauss S, Chin PS, Dyrting KC, Ellis TM, et al. H9N2 influenza viruses possess-
ing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol. 2000; 74
(20):9372–80. Epub 2000/09/23. https://doi.org/10.1128/jvi.74.20.9372-9380.2000 PMID: 11000205;
PubMed Central PMCID: PMC112365.
10. Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, et al. H7N9 influenza viruses are transmissible in ferrets
by respiratory droplet. Science (New York, NY). 2013; 341(6144):410–4. Epub 2013/07/23. https://doi.
org/10.1126/science.1240532 PMID: 23868922.
11. Chen H, Yuan H, Gao R, Zhang J, Wang D, Xiong Y, et al. Clinical and epidemiological characteristics
of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet (London,
England). 2014; 383(9918):714–21. Epub 2014/02/11. https://doi.org/10.1016/S0140-6736(14)60111-2
PMID: 24507376.
12. Wang Y, Niu S, Zhang B, Yang C, Zhou Z. The whole genome analysis for the first human infection with
H10N3 influenza virus in China. J Infect. 2021. Epub 2021/07/01. https://doi.org/10.1016/j.jinf.2021.06.
021 PMID: 34192524.
PLOS PATHOGENS H9N2 virus-derived M1 protein promotes H5N6 virus human infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1010098 December 3, 2021 21 / 24
13. Bi Y, Chen Q, Wang Q, Chen J, Jin T, Wong G, et al. Genesis, Evolution and Prevalence of H5N6 Avian
Influenza Viruses in China. Cell Host & Microbe. 2016; 20(6):810–21. https://doi.org/10.1016/j.chom.
2016.10.022 PMID: 27916476
14. Beerens N, Heutink R, Pritz-Verschuren S, Germeraad EA, Bergervoet SA, Harders F, et al. Genetic
relationship between poultry and wild bird viruses during the highly pathogenic avian influenza H5N6
epidemic in the Netherlands, 2017–2018. Transboundary and emerging diseases. 2019; 66(3):1370–8.
Epub 04/05. https://doi.org/10.1111/tbed.13169 PMID: 30874364.
15. Bonilla-Aldana DK, Aguirre-Florez M, Villamizar-Peña R, Gutiérrez-Ocampo E, Henao-Martı́nez JF,
Cvetkovic-Vega A, et al. After SARS-CoV-2, will H5N6 and other influenza viruses follow the pandemic
path? Le infezioni in medicina. 2020; 28(4):475–85. Epub 2020/12/02. PMID: 33257621.
16. Cao X, Yang F, Wu H, Xu L. Genetic characterization of novel reassortant H5N6-subtype influenza
viruses isolated from cats in eastern China. Archives of virology. 2017; 162(11):3501–5. Epub 2017/07/
22. https://doi.org/10.1007/s00705-017-3490-2 PMID: 28730524.
17. Li X, Fu Y, Yang J, Guo J, He J, Guo J, et al. Genetic and biological characterization of two novel reas-
sortant H5N6 swine influenza viruses in mice and chickens. Infection, genetics and evolution: journal of
molecular epidemiology and evolutionary genetics in infectious diseases. 2015; 36:462–6. Epub 2015/
08/25. https://doi.org/10.1016/j.meegid.2015.08.017 PMID: 26296602.
18. Bi Y, Liu H, Xiong C, Di L, Shi W, Li M, et al. Novel avian influenza A (H5N6) viruses isolated in migratory
waterfowl before the first human case reported in China, 2014. Scientific reports. 2016; 6:29888. Epub
2016/07/20. https://doi.org/10.1038/srep29888 PMID: 27431568; PubMed Central PMCID:
PMC4949417.
19. Sun H, Pu J, Wei Y, Sun Y, Hu J, Liu L, et al. Highly Pathogenic Avian Influenza H5N6 Viruses Exhibit
Enhanced Affinity for Human Type Sialic Acid Receptor and In-Contact Transmission in Model Ferrets.
J Virol. 2016; 90(14):6235–43. Epub 2016/04/29. https://doi.org/10.1128/JVI.00127-16 PMID:
27122581; PubMed Central PMCID: PMC4936137.
20. Herfst S, Mok CKP, van den Brand JMA, van der Vliet S, Rosu ME, Spronken MI, et al. Human Clade
2.3.4.4 A/H5N6 Influenza Virus Lacks Mammalian Adaptation Markers and Does Not Transmit via the
Airborne Route between Ferrets. mSphere. 2018; 3(1). Epub 2018/01/05. https://doi.org/10.1128/
mSphere.00405-17 PMID: 29299528; PubMed Central PMCID: PMC5750386.
21. Pulit-Penaloza JA, Brock N, Pappas C, Sun X, Belser JA, Zeng H, et al. Characterization of highly path-
ogenic avian influenza H5Nx viruses in the ferret model. Scientific reports. 2020; 10(1):12700. Epub
2020/07/31. https://doi.org/10.1038/s41598-020-69535-5 PMID: 32728042; PubMed Central PMCID:
PMC7391700.
22. Pu J, Wang S, Yin Y, Zhang G, Carter RA, Wang J, et al. Evolution of the H9N2 influenza genotype that
facilitated the genesis of the novel H7N9 virus. Proceedings of the National Academy of Sciences of the
United States of America. 2015; 112(2):548–53. Epub 2014/12/31. https://doi.org/10.1073/pnas.
1422456112 PMID: 25548189; PubMed Central PMCID: PMC4299237.
23. Rossman JS, Lamb RA. Influenza virus assembly and budding. Virology. 2011; 411(2):229–36. Epub
2011/01/18. https://doi.org/10.1016/j.virol.2010.12.003 PMID: 21237476; PubMed Central PMCID:
PMC3086653.
24. Cross TA, Dong H, Sharma M, Busath DD, Zhou HX. M2 protein from influenza A: from multiple struc-
tures to biophysical and functional insights. Current opinion in virology. 2012; 2(2):128–33. Epub 2012/
04/10. https://doi.org/10.1016/j.coviro.2012.01.005 PMID: 22482709; PubMed Central PMCID:
PMC3322387.
25. Cao S, Liu X, Yu M, Li J, Jia X, Bi Y, et al. A nuclear export signal in the matrix protein of Influenza A
virus is required for efficient virus replication. J Virol. 2012; 86(9):4883–91. Epub 2012/02/22. https://
doi.org/10.1128/JVI.06586-11 PMID: 22345442; PubMed Central PMCID: PMC3347328.
26. Ye Z, Robinson D, Wagner RR. Nucleus-targeting domain of the matrix protein (M1) of influenza virus. J
Virol. 1995; 69(3):1964–70. Epub 1995/03/01. https://doi.org/10.1128/JVI.69.3.1964-1970.1995 PMID:
7853543; PubMed Central PMCID: PMC188818.
27. Martin K, Helenius A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein
(M1) promotes export and inhibits import. Cell. 1991; 67(1):117–30. Epub 1991/10/04. https://doi.org/
10.1016/0092-8674(91)90576-k PMID: 1913813.
28. Calder LJ, Wasilewski S, Berriman JA, Rosenthal PB. Structural organization of a filamentous influenza
A virus. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107
(23):10685–90. Epub 2010/05/26. https://doi.org/10.1073/pnas.1002123107 PMID: 20498070;
PubMed Central PMCID: PMC2890793.
29. Chlanda P, Mekhedov E, Waters H, Sodt A, Schwartz C, Nair V, et al. Palmitoylation Contributes to
Membrane Curvature in Influenza A Virus Assembly and Hemagglutinin-Mediated Membrane Fusion.
Journal of virology. 2017; 91(21):e00947–17. https://doi.org/10.1128/JVI.00947-17 PMID: 28794042.
PLOS PATHOGENS H9N2 virus-derived M1 protein promotes H5N6 virus human infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1010098 December 3, 2021 22 / 24
30. Nao N, Kajihara M, Manzoor R, Maruyama J, Yoshida R, Muramatsu M, et al. A Single Amino Acid in
the M1 Protein Responsible for the Different Pathogenic Potentials of H5N1 Highly Pathogenic Avian
Influenza Virus Strains. PloS one. 2015; 10(9):e0137989. Epub 2015/09/15. https://doi.org/10.1371/
journal.pone.0137989 PMID: 26368015; PubMed Central PMCID: PMC4569272.
31. Brown EG, Liu H, Kit LC, Baird S, Nesrallah M. Pattern of mutation in the genome of influenza A virus
on adaptation to increased virulence in the mouse lung: identification of functional themes. Proceedings
of the National Academy of Sciences of the United States of America. 2001; 98(12):6883–8. Epub
2001/05/24. https://doi.org/10.1073/pnas.111165798 PMID: 11371620; PubMed Central PMCID:
PMC34447.
32. Lakdawala SS, Lamirande EW, Suguitan AL Jr., Wang W, Santos CP, Vogel L, et al. Eurasian-origin
gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pan-
demic H1N1 influenza virus. PLoS pathogens. 2011; 7(12):e1002443. Epub 2012/01/14. https://doi.org/
10.1371/journal.ppat.1002443 PMID: 22241979; PubMed Central PMCID: PMC3248560.
33. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies.
Bioinformatics (Oxford, England). 2014; 30(9):1312–3. Epub 2014/01/24. https://doi.org/10.1093/
bioinformatics/btu033 PMID: 24451623; PubMed Central PMCID: PMC3998144.
34. Quan FS, Steinhauer D, Huang C, Ross TM, Compans RW, Kang S-M. A bivalent influenza VLP vac-
cine confers complete inhibition of virus replication in lungs. Vaccine. 2008; 26(26):3352–61. Epub 04/
11. https://doi.org/10.1016/j.vaccine.2008.03.055 PMID: 18468740.
35. Chlanda P, Schraidt O, Kummer S, Riches J, Oberwinkler H, Prinz S, et al. Structural Analysis of the
Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology. Journal of
virology. 2015; 89(17):8957–66. Epub 06/17. https://doi.org/10.1128/JVI.00592-15 PMID: 26085153.
36. Tian Y, Ma L, Gong M, Su G, Zhu S, Zhang W, et al. Protein Profiling and Sizing of Extracellular Vesi-
cles from Colorectal Cancer Patients via Flow Cytometry. ACS nano. 2018; 12(1):671–80. Epub 2018/
01/05. https://doi.org/10.1021/acsnano.7b07782 PMID: 29300458.
37. Zhu S, Ma L, Wang S, Chen C, Zhang W, Yang L, et al. Light-scattering detection below the level of sin-
gle fluorescent molecules for high-resolution characterization of functional nanoparticles. ACS nano.
2014; 8(10):10998–1006. Epub 2014/10/10. https://doi.org/10.1021/nn505162u PMID: 25300001;
PubMed Central PMCID: PMC4212780.
38. Jiang W, Ma P, Deng L, Liu Z, Wang X, Liu X, et al. Hepatitis A virus structural protein pX interacts with
ALIX and promotes the secretion of virions and foreign proteins through exosome-like vesicles. J Extra-
cell Vesicles. 2020; 9(1):1716513-. https://doi.org/10.1080/20013078.2020.1716513 PMID: 32082513.
39. He J, Sun E, Bujny MV, Kim D, Davidson MW, Zhuang X. Dual function of CD81 in influenza virus
uncoating and budding. PLoS pathogens. 2013; 9(10):e1003701–e. Epub 10/10. https://doi.org/10.
1371/journal.ppat.1003701 PMID: 24130495.
40. Hutchinson EC, Charles PD, Hester SS, Thomas B, Trudgian D, Martı́nez-Alonso M, et al. Conserved
and host-specific features of influenza virion architecture. Nat Commun. 2014; 5:4816-. https://doi.org/
10.1038/ncomms5816 PMID: 25226414.
41. Miyake Y, Keusch JJ, Decamps L, Ho-Xuan H, Iketani S, Gut H, et al. Influenza virus uses transportin 1
for vRNP debundling during cell entry. Nature microbiology. 2019; 4(4):578–86. Epub 2019/01/30.
https://doi.org/10.1038/s41564-018-0332-2 PMID: 30692667.
42. Ye X, Wang J, Qiao Z, Yang D, Wang J, Abudureyimu A, et al. Quantitative proteomic analysis of
MDCK cell adhesion. Molecular omics. 2021; 17(1):121–9. Epub 2020/11/18. https://doi.org/10.1039/
d0mo00055h PMID: 33201162.
43. Ge Y, Kang Y, Cassidy RM, Moon K-M, Lewis R, Wong ROL, et al. Clptm1 Limits Forward Trafficking of
GABA(A) Receptors to Scale Inhibitory Synaptic Strength. Neuron. 2018; 97(3):596-610.e8. Epub 01/
25. https://doi.org/10.1016/j.neuron.2017.12.038 PMID: 29395912.
44. Hui EK-W, Nayak DP. Role of G protein and protein kinase signalling in influenza virus budding in
MDCK cells. Journal of General Virology. 2002; 83(12):3055–66. https://doi.org/10.1099/0022-1317-
83-12-3055.
45. Barman S, Ali A, Hui EKW, Adhikary L, Nayak DP. Transport of viral proteins to the apical membranes
and interaction of matrix protein with glycoproteins in the assembly of influenza viruses. Virus Research.
2001; 77(1):61–9. https://doi.org/10.1016/S0168-1702(01)00266-0 PMID: 11451488
46. Amorim MJ, Bruce EA, Read EK, Foeglein A, Mahen R, Stuart AD, et al. A Rab11- and microtubule-
dependent mechanism for cytoplasmic transport of influenza A virus viral RNA. J Virol. 2011; 85
(9):4143–56. Epub 2011/02/11. https://doi.org/10.1128/JVI.02606-10 PMID: 21307188; PubMed Cen-
tral PMCID: PMC3126276.
47. Bhagwat AR, Le Sage V, Nturibi E, Kulej K, Jones J, Guo M, et al. Quantitative live cell imaging reveals
influenza virus manipulation of Rab11A transport through reduced dynein association. Nat Commun.
2020; 11(1):23-. https://doi.org/10.1038/s41467-019-13838-3 PMID: 31911620.
PLOS PATHOGENS H9N2 virus-derived M1 protein promotes H5N6 virus human infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1010098 December 3, 2021 23 / 24
48. Bi Y, Li J, Li S, Fu G, Jin T, Zhang C, et al. Dominant subtype switch in avian influenza viruses during
2016–2019 in China. Nat Commun. 2020; 11(1):5909-. https://doi.org/10.1038/s41467-020-19671-3
PMID: 33219213.
49. Khan SU, Anderson BD, Heil GL, Liang S, Gray GC. A Systematic Review and Meta-Analysis of the
Seroprevalence of Influenza A(H9N2) Infection Among Humans. The Journal of infectious diseases.
2015; 212(4):562–9. Epub 2015/02/26. https://doi.org/10.1093/infdis/jiv109 PMID: 25712969; PubMed
Central PMCID: PMC4598807.
50. Quan C, Wang Q, Zhang J, Zhao M, Dai Q, Huang T, et al. Avian Influenza A Viruses among Occupa-
tionally Exposed Populations, China, 2014–2016. Emerging infectious diseases. 2019; 25(12):2215–
25. Epub 2019/11/20. https://doi.org/10.3201/eid2512.190261 PMID: 31742536; PubMed Central
PMCID: PMC6874249.
51. Freissmuth M, Casey PJ, Gilman AG. G proteins control diverse pathways of transmembrane signaling.
FASEB journal: official publication of the Federation of American Societies for Experimental Biology.
1989; 3(10):2125–31. Epub 1989/08/01. PMID: 2546847.
52. Pimplikar SW, Simons K. Regulation of apical transport in epithelial cells by a Gs class of heterotrimeric
G protein. Nature. 1993; 362(6419):456–8. Epub 1993/04/01. https://doi.org/10.1038/362456a0 PMID:
8385268.
53. Bebelman MP, Crudden C, Pegtel DM, Smit MJ. The Convergence of Extracellular Vesicle and GPCR
Biology. Trends in pharmacological sciences. 2020; 41(9):627–40. Epub 2020/07/28. https://doi.org/10.
1016/j.tips.2020.07.001 PMID: 32711926.
54. Ridley AJ. Membrane ruffling and signal transduction. BioEssays: news and reviews in molecular, cellu-
lar and developmental biology. 1994; 16(5):321–7. Epub 1994/05/01. https://doi.org/10.1002/bies.
950160506 PMID: 8024541.
55. Wang G, Jiang L, Wang J, Zhang J, Kong F, Li Q, et al. The G Protein-Coupled Receptor FFAR2 Pro-
motes Internalization during Influenza A Virus Entry. J Virol. 2020; 94(2). Epub 2019/11/07. https://doi.
org/10.1128/jvi.01707-19 PMID: 31694949; PubMed Central PMCID: PMC6955252.
56. Kuwahara T, Yamayoshi S, Noda T, Kawaoka Y. G Protein Pathway Suppressor 1 Promotes Influenza
Virus Polymerase Activity by Activating the NF-κB Signaling Pathway. mBio. 2019; 10(6). Epub 2019/
12/19. https://doi.org/10.1128/mBio.02867-19 PMID: 31848286; PubMed Central PMCID:
PMC6918087.
57. Miller MA PW, Schwartz T. Creating the CIPRES Science Gateway for inference of large phylogenetic
trees. In Proceedings of the Gateway Computing Environments Workshop (GCE). 2010;(14 November
2010, New Orleans, LA).
58. Sun Y, Qin K, Wang J, Pu J, Tang Q, Hu Y, et al. High genetic compatibility and increased pathogenicity
of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses. Proceedings of
the National Academy of Sciences of the United States of America. 2011; 108(10):4164–9. Epub 2011/
03/04. https://doi.org/10.1073/pnas.1019109108 PMID: 21368167; PubMed Central PMCID:
PMC3054021.
59. Reed LJ. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27.
60. Pu J, Sun H, Qu Y, Wang C, Gao W, Zhu J, et al. M Gene Reassortment in H9N2 Influenza Virus Pro-
motes Early Infection and Replication: Contribution to Rising Virus Prevalence in Chickens in China.
Journal of virology. 2017; 91(8):e02055–16. https://doi.org/10.1128/JVI.02055-16 PMID: 28148803.
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